Biotech startups in Ile-de-France, France
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Biolevate | Paris | Series A | $34.4M | 2026-09-21 |
| WhiteLab Genomics | Paris | Series B | $26.0M | 2026-10-05 |
| Standing Ovation | Paris | Series B | $28.6M | 2026-03-31 |
| Generare | Paris | Series A | $23.1M | 2026-04-02 |
| En Carta Diagnostics | Paris | Seed | $3.4M | 2026-07-10 |
| BioFluff | Paris | Seed | $2.5M | 2026-09-02 |
| Amatera | Paris | Seed | $7.0M | 2026-03-04 |
| Genomines | Paris | Series A | $45.0M | 2025-09-17 |
8 rows of the CSV in 5 of its 18 columns.
- The 124 biotech startups in Ile-de-France, France have raised $1.5B in total.
- 19 of them closed their most recent round in the last 12 months, $290.7M combined.
- The largest of those rounds is Cyllene Therapeutics' $37.7M Series C, dated July 2026.
- The most recent is Rivercell's $25.0M seed round on 7 October 2026.
- Bpifrance is an investor in 9 of them, more than any other fund.
- Health care is the most common other sector, with 83 companies (67%).
- 30% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (48% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 124| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris | Series B | $26.0M | 2026-10-05 | $36.5M | Y Combinator, Omnes Capital | 11 to 50 | 2019 |
| Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris | Seed | $2.5M | 2026-09-02 | $3.2M | SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 | 1 to 10 | 2022 |
| En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. | Biotech | Paris | Seed | $3.4M | 2026-07-10 | $7.3M | CentraleSupélec Venture | 11 to 50 | 2022 |
| Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
| Standing Ovation | Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. | Biotech | Paris | Series B | $28.6M | 2026-03-31 | $53.8M | Bpifrance, Seventure Partners, Big Idea Ventures +2 | 11 to 50 | 2021 |
| Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| Genomines | Genomines is a biotechnology company that uses plants for mining. | Biotech | Paris | Series A | $45.0M | 2025-09-17 | $61.8M | Bpifrance, Elemental Impact, Lowercarbon Capital | 11 to 50 | 2021 |
| Bioptimus | Bioptimus builds a foundation AI model for biology to accelerate scientific discovery. | Artificial intelligence | Paris | Series A | $41.0M | 2025-01-14 | Bpifrance, Headline, Cathay Innovation +1 | 1 to 10 | 2024 | |
| CarThera | CarThera designs therapeutic ultrasound medical devices for treating brain disorders. | Biotech | Paris | Series B | $4.8M | 2023-12-11 | European Innovation Council, Supernova Invest, Unorthodox Ventures +1 | 1 to 10 | 2010 | |
| Gradient Denervation Technologies | Gradient Denervation Technologies develops a transvascular medical device for treating pulmonary hypertension. | Biotech | Paris | Series A | $15.0M | 2023-09-07 | MedTech Innovator, Sofinnova Partners, Thuja Capital +1 | 11 to 50 | 2019 | |
| Echoliv | Echoliv develops medical-grade AI for liver ultrasound to assist radiologists and hepatologists. | Artificial intelligence | Paris | Pre-seed | $61K | 2022-07-07 | Bpifrance, WILCO, IMT Starter | 1 to 10 | 2021 |
Table 1. Biotech startups in Ile-de-France, France: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Biolevate | Biolevate provides an AI platform that helps life sciences teams run regulated operations with auditable workflows. | Artificial intelligence | Paris | Series A | $34.4M | 2026-09-21 | $40.7M | Bpifrance, EQT Ventures | 11 to 50 | 2024 |
| 2 | Standing Ovation | Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. | Biotech | Paris | Series B | $28.6M | 2026-03-31 | $53.8M | Bpifrance, Seventure Partners, Big Idea Ventures +2 | 11 to 50 | 2021 |
| 3 | WhiteLab Genomics | WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. | Artificial intelligence | Paris | Series B | $26.0M | 2026-10-05 | $36.5M | Y Combinator, Omnes Capital | 11 to 50 | 2019 |
| 4 | Generare | Generare discovers new medicines and valuable molecules from soil bacteria. | Artificial intelligence | Paris | Series A | $23.1M | 2026-04-02 | $32.2M | Better Angle, Teampact ventures, Galion.exe +1 | 11 to 50 | 2022 |
| 5 | Amatera | Amatera is a biotechnology research company that develops new coffee varieties. | Biotech | Paris | Seed | $7.0M | 2026-03-04 | $8.6M | AgFunder, Joyance Partners, Exceptional Ventures | 11 to 50 | 2022 |
| 6 | En Carta Diagnostics | En Carta Diagnostics develops molecular diagnostic technologies for detecting DNA and RNA pathogens at the point of care. | Biotech | Paris | Seed | $3.4M | 2026-07-10 | $7.3M | CentraleSupélec Venture | 11 to 50 | 2022 |
| 7 | BioFluff | BioFluff creates plant-based fur, shearling, and plush for the fashion, interior, and toy industries. | Biotech | Paris | Seed | $2.5M | 2026-09-02 | $3.2M | SOSV, SOSV SF & NY (Fka IndieBio), Joyance Partners +1 | 1 to 10 | 2022 |
Table 2. Biotech startups in Ile-de-France, France: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bpifrance | Government investment office | Maisons-alfort, France | 9 | 7% | 2 | Biolevate, Standing Ovation |
| 2 | Kurma Partners | Venture capital firm | Paris, France | 4 | 3% | ||
| 3 | Omnes Capital | Private equity firm | Paris, France | 3 | 2% | 1 | WhiteLab Genomics |
| 4 | Astanor Ventures | Venture capital firm | Luxembourg, Belgium | 2 | 2% | 2 | BioFluff, Standing Ovation |
| 5 | Seventure Partners | Venture capital firm | Paris, France | 2 | 2% | 1 | Standing Ovation |
| 6 | Joyance Partners | Venture capital firm | San Francisco, United States | 2 | 2% | 2 | BioFluff, Amatera |
| 7 | AgFunder | Micro VC fund | San Francisco, United States | 2 | 2% | 1 | Amatera |
| 8 | Sofinnova Partners | Venture capital firm | Paris, France | 2 | 2% | ||
| 9 | European Innovation Council | Startup accelerator | Brussels, Belgium | 2 | 2% | ||
| 10 | Elaia | Venture capital firm | Paris, France | 2 | 2% | ||
| 11 | IMT Starter | Startup incubator | Évry, France | 2 | 2% | ||
| 12 | EQT Ventures | Venture capital firm | Stockholm, Sweden | 1 | 1% | 1 | Biolevate |
| 13 | Y Combinator | Startup accelerator | Mountain View, United States | 1 | 1% | 1 | WhiteLab Genomics |
| 14 | PeakBridge | Venture capital firm | Valletta, Malta | 1 | 1% | 1 | Standing Ovation |
| 15 | Big Idea Ventures | Startup accelerator | New York, United States | 1 | 1% | 1 | Standing Ovation |
Table 3. Biotech startups in Ile-de-France, France: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 83 | 67% | $1.2B |
| Software | 21 | 17% | $160.0M |
| Artificial intelligence | 13 | 10% | $155.6M |
| Hardware | 6 | 5% | $7.6M |
| Energy | 2 | 2% | |
| Education | 2 | 2% | |
| Fintech | 1 | 1% | $4.4M |
Table 4. Biotech startups in Ile-de-France, France by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Biotech startups in Ile-de-France, France by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Paris | 93 | 75% |
| Évry | 10 | 8% |
| Romainville | 6 | 5% |
| Suresnes | 3 | 2% |
| Orsay | 2 | 2% |
| Villejuif | 1 | 1% |
| Neuilly-sur-seine | 1 | 1% |
| Malakoff | 1 | 1% |
| Boulogne-billancourt | 1 | 1% |
| Saulx-les-chartreux | 1 | 1% |
| Montrouge | 1 | 1% |
| Massy | 1 | 1% |
Table 6. Biotech startups in Ile-de-France, France by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 2 | 11% | $51.0M |
| September 2026 | 3 | 16% | $37.1M |
| July 2026 | 2 | 11% | $41.2M |
| June 2026 | 1 | 5% | $34.0M |
| May 2026 | 2 | 11% | $23.7M |
| April 2026 | 1 | 5% | $23.1M |
| March 2026 | 3 | 16% | $42.6M |
| January 2026 | 3 | 16% | $28.8M |
| December 2025 | 1 | 5% | $4.2M |
| November 2025 | 1 | 5% | $5.1M |
Table 7. Biotech startups in Ile-de-France, France: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 17 | 14% | $281.5M |
| 2025 | 16 | 13% | $222.3M |
| 2024 | 11 | 9% | $116.1M |
| 2023 | 12 | 10% | $187.8M |
| 2022 | 12 | 10% | $182.5M |
| 2021 | 12 | 10% | $254.9M |
Table 8. Biotech startups in Ile-de-France, France by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 10 | 8% |
| 2020 to 2022 | 27 | 22% |
| 2015 to 2019 | 39 | 32% |
| 2010 to 2014 | 22 | 18% |
| Before 2010 | 25 | 20% |
Table 9. Biotech startups in Ile-de-France, France by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 55 | 45% |
| 11 to 50 | 58 | 48% |
| 51 to 100 | 7 | 6% |
| 101 to 250 | 2 | 2% |
Table 10. Biotech startups in Ile-de-France, France by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Ile-de-France, France. On 16 November 2026 that is 124 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 124 rows: 15 have no round amount, 0 no city and 43 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Ile-de-France, France are on the list?
- 124, in the file dated 16 November 2026. 19 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.